CHMA Stock Performance, Insider Transaction and News

CHMA - Chiasma, Inc.

Market Cap	237.81M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-89.94M	Forward P/E	-5.30	EPS next Y	-	50D Avg Chg	-14.00%
Sales	3.03M	PEG	-	EPS past 5Y	-	200D Avg Chg	-3.00%
Dividend	N/A	Price/Book	3.47	EPS next 5Y	46.30%	52W High Chg	-34.00%
Recommedations	2.40	Quick Ratio	6.70	Shares Outstanding	63.25M	52W Low Chg	36.00%
Insider Own	0.58%	ROA	-37.05%	Shares Float	33.80M	Beta	1.26
Inst Own	76.11%	ROE	-133.81%	Shares Shorted/Prior	756.01K/2.61M	Price	3.76
Gross Margin	95.78%	Profit Margin	-	Avg. Volume	996,380	Target Price	-
Oper. Margin	-2,408.65%	Earnings Date	Mar 2	Volume	8,196,718	Change	-6.00%

Healthcare | Biotechnology | United States

About Chiasma, Inc.

Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.

CHMA Chatroom

Quantisnow Posted - 2 years ago

$AMYT $CHMA 📰 Amryt Reports Q3 2022 Financial and Operational Results https://quantisnow.com/i/3622683?utm_source=stocktwits 45 seconds delayed.

Newsfilter Posted - 2 years ago

$AMYT $CHMA Amryt Reports Q3 2022 Financial and Operational Results https://newsfilter.io/a/2a07ea650fbdec8560791d667bbc78a4

bigwhalealert Posted - 2 years ago

$CHMA BUY/SELL METER Alert Cross 41% + 🚀 https://t8sk.com/CHMA

Quantisnow Posted - 2 years ago

$AMYT $CHMA 📰 Amryt Reports Record Q2 2022 Results https://quantisnow.com/i/3235087?utm_source=stocktwits 45 seconds delayed.

Newsfilter Posted - 2 years ago

$AMYT $CHMA Amryt Reports Record Q2 2022 Results https://newsfilter.io/a/9096b62cf3ab85d888083e744e52d8eb

bigwhalealert Posted - 2 years ago

$CHMA BUY/SELL METER Signal Cross 3% + 🚀 https://t8sk.com/CHMA

bigwhalealert Posted - 2 years ago

$CHMA BUY/SELL METER Signal Cross 3% + 🚀 https://t8sk.com/CHMA

STCKPRO Posted - 2 years ago

$CHMA NEW ARTICLE : SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer https://www.stck.pro/news/CHMA/31031939

Stonkmoon Posted - 2 years ago

$CHMA 2022-07-12 05:00 ET SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer https://stonkmoon.com/news/CHMA/00d76be9bf5ae2b30685fa9f78c8053d

fla Posted - 2 years ago

$CHMA [15s. delayed]: Issued Press Release on July 12, 05:00:00: SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chi https://s.flashalert.me/aSSwL

Quantisnow Posted - 2 years ago

$CHMA $NRSN 📰 SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer https://quantisnow.com/i/3129970?utm_source=stocktwits 45 seconds delayed.

Stock_Titan Posted - 2 years ago

$CHMA $NRSN SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer https://www.stocktitan.net/news/CHMA/spy-biotech-appoints-seasoned-biotech-executive-mark-leuchtenberger-u6wwq7hauomr.html

Newsfilter Posted - 2 years ago

$CHMA $NRSN SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer https://newsfilter.io/a/df0a356f8e01a34e885e8f1f0a3afbef

AlertsAndNews Posted - 2 years ago

$CHMA coming back. Squeezing a bit here

Quantisnow Posted - 2 years ago

$AMYT $CHMA 📰 Amryt Reports Record Q1 2022 Results https://quantisnow.com/i/2824353?utm_source=stocktwits 45 seconds delayed.

Newsfilter Posted - 2 years ago

$AMYT $CHMA Amryt Reports Record Q1 2022 Results https://newsfilter.io/a/6bdb5689d0d5b957941a7ceb2217e43c

bigwhalealert Posted - 2 years ago

$CHMA BUY/SELL METER NOW Change 3% + 🚀 https://t8sk.com/CHMA

Quantisnow Posted - 2 years ago

$AMYT $CHMA 📰 Amryt Announces 22% growth in FY 2021 Revenues to $222.5M https://quantisnow.com/i/2544778?utm_source=stocktwits 45 seconds delayed.

Newsfilter Posted - 2 years ago

$AMYT $CHMA Amryt Announces 22% growth in FY 2021 Revenues to $222.5M https://newsfilter.io/a/e8fb29c6714a0dbe090a292d64833424

bigwhalealert Posted - 2 years ago

$CHMA BUY/SELL METER NOW Change 3% + 🚀 https://t8sk.com/CHMA

bigwhalealert Posted - 2 years ago

$CHMA TA Stats Today's Change 2% + 🚀 https://t8sk.com/CHMA

bigwhalealert Posted - 2 years ago

$CHMA : Latest TA 🚀 🦍: https://t8sk.com/CHMA- 22% 🚀

PennySearch Posted - 2 years ago

$CHMA Jefferies gave CHMA a Buy stock rating on 2020-08-13. Find top penny stocks with PennySearch before the moon launch. https://play.google.com/store/apps/details?id=org.invescent.pennysearch&hl=en_US&gl=US

PennySearch Posted - 2 years ago

bigwhalealert Posted - 01/27/22

$CHMA : Twitter Latest Twits 🚀 🦍: https://t8sk.com/CHMA- 22% 🚀

bigwhalealert Posted - 2 years ago

$CHMA Twits Stats Today's Change 2% + 🚀 https://t8sk.com/CHMA

macroaxis Posted - 2 years ago

$CHMA - Implied volatility is down to 24.4319 for Chiasma https://www.macroaxis.com/stock-options/CHMA/Chiasma?utm_source=dlvr.it&utm_medium=stocktwits

bigwhalealert Posted - 2 years ago

$CHMA Twits Stats Today's Change 2% + 🚀 https://t8sk.com/CHMA

Analyst Ratings

Jefferies	Buy	Aug 13, 20
HC Wainwright & Co.	Buy	Aug 12, 20
HC Wainwright & Co.	Buy	Jun 29, 20
HC Wainwright & Co.	Buy	Mar 17, 20
Piper Jaffray	Overweight	Jul 31, 19
Cantor Fitzgerald	Overweight	Mar 7, 19
H.C. Wainwright	Buy	Feb 14, 19
Barclays	Underweight	Jan 17, 17
Barclays	Equal-Weight	Apr 24, 16